Endovascular Treatment in Patients with Persistent Internal Carotid Artery Occlusion after Intravenous Tissue Plasminogen Activator: A Clinical Effectiveness Study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hong, Jeong-Ho | - |
dc.contributor.author | Sohn, Sung-Il | - |
dc.contributor.author | Kang, Jihoon | - |
dc.contributor.author | Jang, Min Uk | - |
dc.contributor.author | Kim, Beom Joon | - |
dc.contributor.author | Han, Moon-Ku | - |
dc.contributor.author | Park, Tai Hwan | - |
dc.contributor.author | Park, Sang-Soon | - |
dc.contributor.author | Lee, Kyung Bok | - |
dc.contributor.author | Lee, Byung-Chul | - |
dc.contributor.author | Yu, Kyung-Ho | - |
dc.contributor.author | Oh, Mi Sun | - |
dc.contributor.author | Cha, Jae Kwan | - |
dc.contributor.author | Kim, Dae-Hyun | - |
dc.contributor.author | Lee, Jun | - |
dc.contributor.author | Lee, Soo Joo | - |
dc.contributor.author | Ko, Youngchai | - |
dc.contributor.author | Kim, Jae Guk | - |
dc.contributor.author | Park, Jong-Moo | - |
dc.contributor.author | Kang, Kyusik | - |
dc.contributor.author | Cho, Yong-Jin | - |
dc.contributor.author | Hong, Keun-Sik | - |
dc.contributor.author | Cho, Ki-Hyun | - |
dc.contributor.author | Kim, Joon-Tae | - |
dc.contributor.author | Choi, Jay Chol | - |
dc.contributor.author | Lee, Juneyoung | - |
dc.contributor.author | Lee, Ji Sung | - |
dc.contributor.author | Gorelick, Philip B. | - |
dc.contributor.author | Bae, Hee-Joon | - |
dc.date.accessioned | 2021-09-03T16:19:39Z | - |
dc.date.available | 2021-09-03T16:19:39Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2016-12 | - |
dc.identifier.issn | 1015-9770 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/86688 | - |
dc.description.abstract | Background: There has been no large-scale trial comparing endovascular treatment (add-on EVT) after intravenous tissue plasminogen activator (IV tPA) and IV tPA alone in acute ischemic stroke (AIS) caused by internal carotid artery occlusion (ICAO). We aimed at investigating the effectiveness and safety of add-on EVT after IV tPA in AIS patients with ICAO. Methods: Between March 2010 and March 2013, 3,689 consecutive ischemic stroke patients who were hospitalized within 4.5 h of onset were identified using a prospective stroke registry at 11 centers in Korea. Among them, patients with persistent ICAO after receiving IV tPA and whose 3-month modified Rankin Scale (mRS) was available were finally enrolled. A propensity score analysis with inverse-probability of treatment weighting was used to eliminate baseline imbalances between those receiving add-on EVT and IV tPA alone. Results: Among 264 patients enrolled in this study (mean age 71.4; male 56.4%; median National Institute of Health Stroke Scale score 15), 117 (44.3%) received add-on EVT. The add-on EVT group had a higher frequency of favorable outcome on the mRS <= 2 (35.0 vs. 18.4%; adjusted OR (aOR) 2.79; 95% CI 1.66-4.67) and lower mortality (17.9 vs. 35.4%; aOR 0.24; 95% CI 0.13-0.42) at 3 months, when compared to the IV tPA-alone group. Add-on EVT did not significantly increase the risk of symptomatic hemorrhage (5.1 vs. 4.1%; aOR 1.01; 95% CI 0.37-2.70). The rate of successful recanalization (thrombolysis in cerebral infarction grade >= 2b) in the add-on EVT group was 69.2%. Conclusions: Compared to an IV tPA alone, add-on EVT can improve clinical outcomes in patients with symptomatic ICAO within 4.5 h of onset without a significant increase of symptomatic hemorrhage. (C) 2016 S. Karger AG, Basel | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KARGER | - |
dc.subject | ACUTE ISCHEMIC-STROKE | - |
dc.subject | IMAGING SELECTION | - |
dc.subject | CT ANGIOGRAPHY | - |
dc.subject | T-PA | - |
dc.subject | THROMBECTOMY | - |
dc.subject | METAANALYSIS | - |
dc.subject | RECANALIZATION | - |
dc.subject | THERAPY | - |
dc.subject | TRIALS | - |
dc.subject | ASSOCIATION | - |
dc.title | Endovascular Treatment in Patients with Persistent Internal Carotid Artery Occlusion after Intravenous Tissue Plasminogen Activator: A Clinical Effectiveness Study | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Juneyoung | - |
dc.identifier.doi | 10.1159/000447599 | - |
dc.identifier.scopusid | 2-s2.0-84978121164 | - |
dc.identifier.wosid | 000390030800010 | - |
dc.identifier.bibliographicCitation | CEREBROVASCULAR DISEASES, v.42, no.5-6, pp.387 - 394 | - |
dc.relation.isPartOf | CEREBROVASCULAR DISEASES | - |
dc.citation.title | CEREBROVASCULAR DISEASES | - |
dc.citation.volume | 42 | - |
dc.citation.number | 5-6 | - |
dc.citation.startPage | 387 | - |
dc.citation.endPage | 394 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.relation.journalWebOfScienceCategory | Peripheral Vascular Disease | - |
dc.subject.keywordPlus | ACUTE ISCHEMIC-STROKE | - |
dc.subject.keywordPlus | IMAGING SELECTION | - |
dc.subject.keywordPlus | CT ANGIOGRAPHY | - |
dc.subject.keywordPlus | T-PA | - |
dc.subject.keywordPlus | THROMBECTOMY | - |
dc.subject.keywordPlus | METAANALYSIS | - |
dc.subject.keywordPlus | RECANALIZATION | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | TRIALS | - |
dc.subject.keywordPlus | ASSOCIATION | - |
dc.subject.keywordAuthor | Thrombolysis | - |
dc.subject.keywordAuthor | Carotid arteries | - |
dc.subject.keywordAuthor | Endovascular revascularization | - |
dc.subject.keywordAuthor | Acute stroke | - |
dc.subject.keywordAuthor | Revascularization | - |
dc.subject.keywordAuthor | Acute stroke intervention | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.